Masahiro Takeuchi

11.6k total citations · 4 hit papers
215 papers, 8.6k citations indexed

About

Masahiro Takeuchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Masahiro Takeuchi has authored 215 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Oncology, 79 papers in Pulmonary and Respiratory Medicine and 34 papers in Surgery. Recurrent topics in Masahiro Takeuchi's work include Colorectal Cancer Treatments and Studies (55 papers), Gastric Cancer Management and Outcomes (40 papers) and Lung Cancer Treatments and Mutations (39 papers). Masahiro Takeuchi is often cited by papers focused on Colorectal Cancer Treatments and Studies (55 papers), Gastric Cancer Management and Outcomes (40 papers) and Lung Cancer Treatments and Mutations (39 papers). Masahiro Takeuchi collaborates with scholars based in Japan, United States and South Korea. Masahiro Takeuchi's co-authors include David V. Goeddel, Jessie Xiong, Zhaodan Cao, Takeshi Kurama, Akinori Takagane, Hong-Bing Shu, Wasaburo Koizumi, Takuo Hara, Mike Rothe and Kimihiko Yanaoka and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Masahiro Takeuchi

207 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

2008 1.5k citations Akinori Takagane, Masahiro Takeuchi et al. profile →
TRAF6 is a signal transducer for interleukin-1

1996 1.1k citations Masahiro Takeuchi et al. profile →
Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

2014 421 citations Hajime Uno, Brian Claggett et al. Journal of Clinical Oncology profile →
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

2019 263 citations Yasuhiro Kodera, Mitsugu Kochi et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masahiro Takeuchi Japan	38	2.8k	2.7k	2.3k	1.6k	1.5k	215	8.6k
Albert Roessner Germany	53	2.9k 1.0×	2.7k 1.0×	4.0k 1.8×	1.1k 0.7×	1.8k 1.2×	443	12.1k
Si Young Song South Korea	51	2.6k 0.9×	3.6k 1.3×	2.1k 0.9×	700 0.4×	1.1k 0.7×	354	9.3k
Tsuyoshi Takahashi Japan	46	5.2k 1.8×	3.5k 1.3×	2.0k 0.9×	1.1k 0.7×	1.2k 0.8×	488	10.1k
Shuji Takiguchi Japan	57	4.7k 1.6×	2.5k 0.9×	2.5k 1.1×	934 0.6×	1.4k 0.9×	432	11.1k
Koji Tanaka Japan	53	2.9k 1.0×	3.7k 1.3×	3.6k 1.6×	1.0k 0.6×	2.7k 1.8×	471	10.9k
Shan Zeng China	46	1.3k 0.4×	1.9k 0.7×	2.8k 1.2×	1.7k 1.1×	1.2k 0.8×	286	7.4k
Tsutomu Masaki Japan	47	2.1k 0.7×	1.9k 0.7×	3.4k 1.5×	913 0.6×	1.5k 1.0×	521	9.7k
Hideaki Shimada Japan	45	2.9k 1.0×	2.7k 1.0×	2.5k 1.1×	1.0k 0.6×	832 0.5×	382	8.3k
Yoshiharu Sakai Japan	61	3.0k 1.1×	5.4k 2.0×	3.2k 1.4×	1.3k 0.8×	1.6k 1.0×	409	11.8k
Rupert Langer Germany	51	2.7k 0.9×	2.3k 0.8×	2.5k 1.1×	525 0.3×	833 0.5×	219	7.7k

Countries citing papers authored by Masahiro Takeuchi

Since Specialization

Citations

This map shows the geographic impact of Masahiro Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Takeuchi more than expected).

Fields of papers citing papers by Masahiro Takeuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Takeuchi. The network helps show where Masahiro Takeuchi may publish in the future.

Co-authorship network of co-authors of Masahiro Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Takeuchi. A scholar is included among the top collaborators of Masahiro Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Takeuchi. Masahiro Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fujimoto, Ayumi, Kana Miyazaki, Kimikazu Yakushijin, et al.. (2025). Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study. Leukemia. 39(4). 909–916. 1 indexed citations

Yasui, Hisateru, Masato Nakamura, Takashi Sagawa, et al.. (2023). Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16. ESMO Open. 8(5). 101636–101636. 2 indexed citations

Murakami, Tomoaki, Satoshi Kato, Takashi Shigeeda, et al.. (2020). Intensive treat-to-target statin therapy and severity of diabetic retinopathy complicated by hypercholesterolaemia. Eye. 35(8). 2221–2228. 4 indexed citations

Tanaka, Hiroaki, Hideki Sakagami, Naoki Kaneko, et al.. (2019). Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression. Molecular Cancer Therapeutics. 18(8). 1366–1373. 15 indexed citations

Sunakawa, Yu, Masato Nakamura, Hironaga Satake, et al.. (2019). RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). Annals of Oncology. 30. iv114–iv114. 3 indexed citations

Miyagawa, Shigeru, Keitaro Domae, Yasushi Yoshikawa, et al.. (2017). Phase I Clinical Trial of Autologous Stem Cell–Sheet Transplantation Therapy for Treating Cardiomyopathy. Journal of the American Heart Association. 6(4). 131 indexed citations

Sunakawa, Yu, Wataru Ichikawa, Akihito Tsuji, et al.. (2016). Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials. Clinical Colorectal Cancer. 16(3). e171–e180. 37 indexed citations

Aotani, Eriko, Tetsutaro Hamano, Akihiko Gemma, et al.. (2016). Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer. International Journal of Clinical Oncology. 21(5). 836–842. 5 indexed citations

Tanigawa, Nobuhiko, Hiroki Yamaue, Shigekazu Ohyama, et al.. (2015). Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial). Gastric Cancer. 19(2). 350–360. 16 indexed citations

10.

Nomoto, Masahiro, Yoshikuni Mizuno, Tomoyoshi Kondo, et al.. (2014). Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Journal of Neurology. 261(10). 1887–1893. 34 indexed citations

11.

Uno, Hajime, Brian Claggett, Lü Tian, et al.. (2014). Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis. Journal of Clinical Oncology. 32(22). 2380–2385. 421 indexed citations breakdown →

12.

Nagatsuma, Akiko Kawano, Chikako Shimizu, Fumiaki Takahashi, et al.. (2013). Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women. Breast Cancer Research and Treatment. 138(3). 941–950. 21 indexed citations

13.

Tsuji, Akihito, Masato Nakamura, Yu Sunakawa, et al.. (2013). A Phase II Study of Cetuximab and MFOLFOX6 in MCRC Including Prospective Early Tumor Shrinkage Analysis (JACCRO-CC05). Annals of Oncology. 24. iv94–iv94. 4 indexed citations

14.

Yamada, Y., Masahiro Takeuchi, Arata Azuma, et al.. (2012). Historical changes in epidemiology of diffuse panbronchiolitis.. PubMed. 29(1). 19–25. 7 indexed citations

15.

Narukawa, Mamoru, et al.. (2008). . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 39(6). 261–268.

16.

Yonemori, Kan, Noriyuki Katsumata, Masayuki Kaneko, et al.. (2006). Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy. Breast Cancer Research and Treatment. 103(3). 313–318. 3 indexed citations

17.

Tateishi, Ukihide, et al.. (2005). Prediction of Lung Adenocarcinoma Without Vessel Invasion. CHEST Journal. 128(5). 3276–3283. 10 indexed citations

18.

Seto, Hiroshi, et al.. (2001). Environmental Factors and Accumulation of Polycyclic Aromatic Hydrocarbons and Carbon in Human Lung. Journal of Japan Society for Atmospheric Environment / Taiki Kankyo Gakkaishi. 36(1). 1–12. 1 indexed citations

19.

Takeuchi, Masahiro, et al.. (1991). Spatial Filtering Velocimetry: Computer Simulation by the Artificial Random Moving Image and Application to the Measurement of the Surface Velocity of Debris Flow. Transactions of the Society of Instrument and Control Engineers. 27(10). 1092–1098. 3 indexed citations

20.

Suwa, Hiroshi, et al.. (1989). Measurement of Surface Velocity of Debris Flows by Spatial Filtering Velocimetry. Transactions of the Society of Instrument and Control Engineers. 25(4). 504–506. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact